Five Critical Challenges in Investigator Site Selection and How Clinical Data Science Can Solve Them
Poor investigator site selection remains a significant driver of spiraling costs and inefficiencies in clinical development.
Gen Li, PhD, MBA
Advertisement
Articles by Gen Li, PhD, MBA
A discussion of the cost and time put into clinical trials.
Advertisement
Latest Updated Articles
Clinical Trials Don't Have to Cost Too Much or Take Too LongPublished: May 8th 2018 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Pfizer’s Stock Reacts to Decreases in 2026 Revenue Projections in Full-Year 2026 Guidance Release
2
Four Republicans Break with House GOP to Force Vote on Extending ACA Tax Credits
3
FDA Approves GSK's Exdensur as Twice-Yearly Add-On Therapy for Severe Asthma
4
Sanofi Reaches Deals with ADEL for Novel Alzheimer’s Disease Drug, Dren Bio for B-cell Depletion Therapy
5